In his current role, Nicholas Gallerani, Ph.D., focuses on scientific communication and collaboration related to the applications and performance of NuProbe’s molecular technologies. Prior to joining NuProbe, he was a Fellow at Columbia Technology Ventures, where he assessed new technologies generated by Columbia University research labs. Nick received his Ph.D. in Pathobiology and Molecular Medicine from Columbia University and has co-authored four scientific publications.
Sequencing Tech Showcase:
NuProbe takes a multi-platform approach to apply breakthrough technologies in genomics research to enable diseases to be detected, treated, and cured at early stages for better outcomes with lower costs.
Emerging solutions for non-invasive cancer monitoring
Learn how NuProbe's proprietary technology addresses current limitations in liquid biopsy